Research and Markets (http://www.researchandmarkets.com/research/8rggsd/global_multiple) has announced the addition of the "Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Multiple Myeloma epidemiology, Multiple Myeloma diagnosed patients, and Multiple Myeloma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Myeloma derived from epidemiological analysis, percentage of patients diagnosed with Multiple Myeloma, and percentage of patients treated with Multiple Myeloma therapy.
The study helps executives estimate Multiple Myeloma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Multiple Myeloma prevalence, Multiple Myeloma diagnosis rate, and Multiple Myeloma treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Multiple Myeloma: Disease Definition
2. Global Multiple Myeloma Patient Flow
3. Multiple Myeloma Patient Flow in the US
4. Multiple Myeloma Patient Flow in Europe
5. Multiple Myeloma Patient Flow in Germany
6. Multiple Myeloma Patient Flow in France
7. Multiple Myeloma Patient Flow in Spain
8. Multiple Myeloma Patient Flow in Italy
9. Multiple Myeloma Patient Flow in UK
10. Multiple Myeloma Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/8rggsd/global_multiple
